Cell & Gene
The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...
April 26, 2024 | News
Thermo Fisher Scientific, the world leader in serving science, opens its inaugural office in Jakarta, Indonesia, marking a pivotal step in its strategic ex...
April 25, 2024 | News
New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene...
April 23, 2024 | News
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-bas...
April 18, 2024 | News
Collaboration aims to develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates to facilitate research leading to translation of...
April 18, 2024 | News
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new l...
April 17, 2024 | News
IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell ...
April 08, 2024 | News
YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...
April 03, 2024 | News
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, anno...
April 01, 2024 | News
EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...
March 28, 2024 | News
Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced the expansion of its gene synthesis services with the launch of a...
March 28, 2024 | News
Nanoscope Therapeutics, a pioneering biotechnology firm, unveiled groundbreaking results from the Phase 2b RESTORE trial of MCO-010...
March 27, 2024 | News
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has par...
March 26, 2024 | News
NeuExcell Therapeutics, a leading biotechnology company focused on in vivo neural regenerative therapies, announces the successful dosing of the ...
March 22, 2024 | News
Most Read
Bio Jobs
News